
Tszfung Jackie Chan
Examiner (ID: 9388, Phone: (571)270-7981 , Office: P/2837 )
| Most Active Art Unit | 2837 |
| Art Unit(s) | 2832, 2837 |
| Total Applications | 1062 |
| Issued Applications | 736 |
| Pending Applications | 111 |
| Abandoned Applications | 237 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16932383
[patent_doc_number] => 20210198272
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-01
[patent_title] => DEEP-SEA FUNGUS-DERIVED ANTHRAQUINONE COMPOUND AND USE THEREOF IN PREPARING ANTI-ALLERGIC DRUGS
[patent_app_type] => utility
[patent_app_number] => 16/726835
[patent_app_country] => US
[patent_app_date] => 2019-12-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2136
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16726835
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/726835 | Deep-sea fungus-derived anthraquinone compound and use thereof in preparing anti-allergic drugs | Dec 24, 2019 | Issued |
Array
(
[id] => 17134780
[patent_doc_number] => 11136326
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-05
[patent_title] => Pyrrolopyrimidine derivatives as TAM inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/684912
[patent_app_country] => US
[patent_app_date] => 2019-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38280
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 1172
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16684912
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/684912 | Pyrrolopyrimidine derivatives as TAM inhibitors | Nov 14, 2019 | Issued |
Array
(
[id] => 15586361
[patent_doc_number] => 20200069715
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-05
[patent_title] => BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF PEDIATRIC CHOLESTATIC LIVER DISEASES
[patent_app_type] => utility
[patent_app_number] => 16/679894
[patent_app_country] => US
[patent_app_date] => 2019-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 53731
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16679894
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/679894 | BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF PEDIATRIC CHOLESTATIC LIVER DISEASES | Nov 10, 2019 | Abandoned |
Array
(
[id] => 16861678
[patent_doc_number] => 11020400
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-01
[patent_title] => Tetrahydropyranyl amino-pyrrolopyrimidinone and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 16/672971
[patent_app_country] => US
[patent_app_date] => 2019-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14112
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16672971
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/672971 | Tetrahydropyranyl amino-pyrrolopyrimidinone and methods of use thereof | Nov 3, 2019 | Issued |
Array
(
[id] => 15865997
[patent_doc_number] => 20200140402
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-07
[patent_title] => CFTR REGULATORS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/666278
[patent_app_country] => US
[patent_app_date] => 2019-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 53499
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16666278
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/666278 | CFTR regulators and methods of use thereof | Oct 27, 2019 | Issued |
Array
(
[id] => 16984594
[patent_doc_number] => 11071744
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-27
[patent_title] => Prodrug salts
[patent_app_type] => utility
[patent_app_number] => 16/665333
[patent_app_country] => US
[patent_app_date] => 2019-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 28546
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 166
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16665333
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/665333 | Prodrug salts | Oct 27, 2019 | Issued |
Array
(
[id] => 16153611
[patent_doc_number] => 20200215038
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-09
[patent_title] => INHIBITORS OF DIHYDROOROTATE DEHYDROGENASE
[patent_app_type] => utility
[patent_app_number] => 16/552569
[patent_app_country] => US
[patent_app_date] => 2019-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21917
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16552569
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/552569 | INHIBITORS OF DIHYDROOROTATE DEHYDROGENASE | Aug 26, 2019 | Abandoned |
Array
(
[id] => 15239517
[patent_doc_number] => 20190374544
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-12
[patent_title] => METHODS AND COMPOSITIONS FOR INHIBITION OF POLYMERASE
[patent_app_type] => utility
[patent_app_number] => 16/543079
[patent_app_country] => US
[patent_app_date] => 2019-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16562
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16543079
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/543079 | Methods and compositions for inhibition of polymerase | Aug 15, 2019 | Issued |
Array
(
[id] => 16221215
[patent_doc_number] => 20200246331
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-06
[patent_title] => Pharmaceutical combinations and their use
[patent_app_type] => utility
[patent_app_number] => 16/535214
[patent_app_country] => US
[patent_app_date] => 2019-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8670
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16535214
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/535214 | Pharmaceutical combinations and their use | Aug 7, 2019 | Abandoned |
Array
(
[id] => 16703127
[patent_doc_number] => 10953040
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-23
[patent_title] => Methods of treating bacterial infections with penam b-lactam antibiotics and branched poly(ethylenimine)
[patent_app_type] => utility
[patent_app_number] => 16/530756
[patent_app_country] => US
[patent_app_date] => 2019-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 23
[patent_no_of_words] => 12901
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 129
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16530756
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/530756 | Methods of treating bacterial infections with penam b-lactam antibiotics and branched poly(ethylenimine) | Aug 1, 2019 | Issued |
Array
(
[id] => 16383154
[patent_doc_number] => 10807976
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-10-20
[patent_title] => Quinolinone five-membered heterocyclic compounds as mutant-isocitrate dehydrogenase inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/517866
[patent_app_country] => US
[patent_app_date] => 2019-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 18916
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16517866
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/517866 | Quinolinone five-membered heterocyclic compounds as mutant-isocitrate dehydrogenase inhibitors | Jul 21, 2019 | Issued |
Array
(
[id] => 15264663
[patent_doc_number] => 20190381065
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-19
[patent_title] => TRICYCLIC DIBENZOTHIAZEPINE TYPE COMPOUNDS FOR USE IN THE THERAPY OF CDKL5 DISORDER
[patent_app_type] => utility
[patent_app_number] => 16/422484
[patent_app_country] => US
[patent_app_date] => 2019-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5911
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16422484
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/422484 | TRICYCLIC DIBENZOTHIAZEPINE TYPE COMPOUNDS FOR USE IN THE THERAPY OF CDKL5 DISORDER | May 23, 2019 | Abandoned |
Array
(
[id] => 14806137
[patent_doc_number] => 20190269678
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-05
[patent_title] => CANCER TREATMENT METHOD
[patent_app_type] => utility
[patent_app_number] => 16/418144
[patent_app_country] => US
[patent_app_date] => 2019-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12783
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16418144
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/418144 | CANCER TREATMENT METHOD | May 20, 2019 | Abandoned |
Array
(
[id] => 14743931
[patent_doc_number] => 20190255139
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-22
[patent_title] => SMAC Mimetic
[patent_app_type] => utility
[patent_app_number] => 16/396888
[patent_app_country] => US
[patent_app_date] => 2019-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14466
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16396888
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/396888 | SMAC mimetic | Apr 28, 2019 | Issued |
Array
(
[id] => 14684897
[patent_doc_number] => 20190241563
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-08
[patent_title] => OCTAHYDRO FUSED AZADECALIN GLUCOCORTICOID RECEPTOR MODULATORS
[patent_app_type] => utility
[patent_app_number] => 16/382474
[patent_app_country] => US
[patent_app_date] => 2019-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19506
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16382474
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/382474 | Octahydro fused azadecalin glucocorticoid receptor modulators | Apr 11, 2019 | Issued |
Array
(
[id] => 14578293
[patent_doc_number] => 20190216755
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-18
[patent_title] => Combination Therapies Using HDAC Inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/364634
[patent_app_country] => US
[patent_app_date] => 2019-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12583
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16364634
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/364634 | Combination therapies using HDAC inhibitors | Mar 25, 2019 | Issued |
Array
(
[id] => 14563897
[patent_doc_number] => 20190209555
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-11
[patent_title] => KETOCONAZOLE ENANTIOMER IN HUMANS
[patent_app_type] => utility
[patent_app_number] => 16/351797
[patent_app_country] => US
[patent_app_date] => 2019-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6708
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16351797
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/351797 | KETOCONAZOLE ENANTIOMER IN HUMANS | Mar 12, 2019 | Abandoned |
Array
(
[id] => 14497637
[patent_doc_number] => 20190192473
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-27
[patent_title] => Use Of 2,5-Dihydroxybenzene Compounds And Derivatives For The Treatment Of Rosacea
[patent_app_type] => utility
[patent_app_number] => 16/292838
[patent_app_country] => US
[patent_app_date] => 2019-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13689
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 255
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16292838
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/292838 | Use Of 2,5-Dihydroxybenzene Compounds And Derivatives For The Treatment Of Rosacea | Mar 4, 2019 | Abandoned |
Array
(
[id] => 14647593
[patent_doc_number] => 20190230925
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-01
[patent_title] => FUNGICIDAL COMPOSITIONS COMPRISING A CARBOXAMIDE
[patent_app_type] => utility
[patent_app_number] => 16/293190
[patent_app_country] => US
[patent_app_date] => 2019-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14166
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16293190
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/293190 | FUNGICIDAL COMPOSITIONS COMPRISING A CARBOXAMIDE | Mar 4, 2019 | Abandoned |
Array
(
[id] => 14497731
[patent_doc_number] => 20190192520
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-27
[patent_title] => TETRAHYDROPYRANYL AMINO-PYRROLOPYRIMIDINONE AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/291224
[patent_app_country] => US
[patent_app_date] => 2019-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14094
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16291224
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/291224 | Tetrahydropyranyl amino-pyrrolopyrimidinone and methods of use thereof | Mar 3, 2019 | Issued |